Liposomal amphotericin B found safe and effective.
D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D016867:Immunocompromised Host; D008081:Liposomes / Q000008:administration & dosage; D009181:Mycoses / Q000188:drug therapy*
D000935:Antifungal Agents; D008081:Liposomes; C068538:liposomal amphotericin B; D000666:Amphotericin B